Cardinal Health reported first-quarter fiscal 2027 revenues of $67.5 billion, a 5% increase from the prior year period. GAAP diluted earnings per share rose 27% to $2.38, while non-GAAP diluted EPS increased 28% to $3.26. The company raised its full-year fiscal 2027 non-GAAP EPS guidance to a range of $12.80 to $13.00, reflecting strong performance in its Pharmaceutical and Specialty Solutions segment and completed share repurchases. Cardinal Health operates as a distributor of pharmaceuticals and medical products.
